| DERMATOLOGÍA PERUANA - VOL. 9, Nº 1, ENERO - JUNIO 1999 |
REFERENCIAS BIBLIOGRÁFICAS
1. Katzung BG. Pharmacology. Autoevaluación, repaso. Manual Moderno S.A. de CV México DF 1997.
2. Johnson C. Membrane receptors. Their Enzymatic Mechanisms of Action and Associated Endocrine Diseases. Rev Med Chile 1998; 126:1304-12.
3. Stone DK. Receptors: Structure and function. Am J Med 1998; 105:144--250.
4. Goodman-Gillman. Las Bases Farmacológicas de la Terapéutica. 9a ed. Vol I. Mc Graw-Hill Interamericana. 1997; 31-44.
5. Caulfield MP, Birdsall NJM. Classification of Muscarinic Acetylcholine Re-ceptors. Pharm Rev 1998; 50 (2).
6. Adem A, Karlson E. Muscarinic Receptor Subtype Selective Toxins. Life Sch 1997; 60: 1069-76.
7. Ganong W. Bases Generales de la Fisiología Médica. 16 Ed Manual Moderno, 1998.
8. Cooper GM. Cell Signaling. En: The Cell a Molecular Approach. Wash-ington DC. Edit Asm Press 1997; 521-60.
9. Gordeladze O, et al. G Protein Implications for Pathophysiology and Dis-ease. fur J Endocrinol 1994; 131: 557-74.
10. Bruce A. Biología Molecular de la Célula. Edit Barcelona - España, 1994.
11. Harper, Bioquímica. 13a Ed Interamericana. Mc Graw. Hill 1997.
12. Izaga C, Izaga G. Fundamentos de Farmacología en Terapéutica. 3ra Ed. pag 737. Postergraph, Medellín-Colombia, 1996.
13. Velasco M. Farmacología, Ed Interamericana McGraw-Hill. Madrid, 1993.
14. Ahlquist RP. A study of the Adrenotropic Receptors. Am J Physiol 1948: 153: 586-600.
15. Blaschko H, Muschoil E. Edi. Catecholamines Handbook of Experimen-tal Pharmacology XXXIII. Springer-Verlag. Berlín, 1972.
16. Dale HH. Adventure in Physiology The Welcome Trust, London, 1953.
17. Stjarne L, et al. Chemical Neurotransmission 75 years. Academic Press. New York, 1981.
18. Hepler JR, Gilman AG. G Proteins. Trends Biochem Sci 1912; 17:333--387.
19.Evans RM. The Steroid and Thyroid Hormone Receptor Superfamily. Sci-ence 1988; 240: 889-95.
20. Hunter KM. The Regulation of Transcription by Phosphorylation. Cell 1992; 70: 375-87.
21. Hubbard SR, Mohammadi M. Autoregulatory Mechanism in Protein. Tyrosine Kinases. J Biol Chem 1998; 273: 11987-90.
22. Linder ME. G Proteins. Sci Am 1992; 267: 36-43.
23. Weatley M, Howl J, Yarwod NJ, et al. Structure and function of. Neurohy-pophysial Hormone Receptors. Biochem Soc Trans 1997; 25: 1046-51.
24. Strugnell SA, DeLuca HF The Vitamin D Receptor - Structure and Tran-scriptional Activation. Proc Soci Exp Biol Med 1997; 215: 223-8.
25. Wiegel NL. Steroid Hormone Receptors and their Regulation by Phos-phorylation. Biochem J 1996; 31: 657-67.
26. Berridge MJ. Inositol triphosphate and Calcium Signalling. Nature 1993; 361:315-25.
27. Clark AJ. The Mode of Action of Drug on Cells. LArnold and Co. London 1993.
28. Kenakin TP, Bond RA, Bonner TI. Definition of Pharmacological Recep-tors. Pharmacol Rev 1992; 44: 351-2.
29. Limbird LE. Cell Surface Receptors, A Short Course on Theory and Method. 2nd Ed. M Nijhoff, Boston, 1995.
30. Rhee SG, Choy KD. Multiple Forms of Phospholipase C Isozymes and their activation Mechanisms. Advances in Second Messenger and Phos-phoprotein Research. Raven Press New York. Vol 26, 1992.
31. Strada SJ, Hidaka H. Advance in Second Messenger and Phosphopro-tein Research. The Biology of Cyclic Nucleotide Phosphodiesterases. Vol 25, Raven Press. New York, 1992.
32. Taussig R, Gilman AG. Mammalian Membrane-Bound Adenylciclases. J Biol Chem 1995:270:1-4.
33. Taylor P et al. Molecular Basis of Pharmacologic Selectivity Principles of Drug Action: The Basis of Pharmacology. 3a Ed. Livingstone, N.Y., 1990.
34. Walton KM, Dixon JR. Protein Tyrosine Phosphatases. Ann Rev Biochem 1993: 62: 101-120.
35. Holdemaekers AC, Van Breda Briesman PH, et al. Myasthenia Gravis AS. A Prototype Autoimmune Receptor Disease. Immun Res 1997; 16: 344-54.
36. Birnbaumer M. Mutations and Disease of G Protein Coupled Receptors J Recept Signal Transduct Res 1995;15:131-60.
